EP
BIIB icon

Eudaimonia Partners’s Biogen BIIB Stock Holding History

Eudaimonia Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$371K Hold
1,722
– – 0.09% 176
2023
Q4 		$446K Sell
1,722
-66
-4% -$16.2K 0.12% 151
2023
Q3 		$460K Sell
1,788
-3,326
-65% -$890K 0.11% 183
2023
Q2 		$1.46M Buy
5,114
+3,072
+150% +$914K 0.33% 73
2023
Q1 		$568K Hold
2,042
– – 0.14% 159
2022
Q4 		$565K Sell
2,042
-20
-1% -$5.65K 0.14% 164
2022
Q3 		$551K Sell
2,062
-12
-0.6% -$2.55K 0.14% 157
2022
Q2 		$423K Hold
2,074
– – 0.08% 245
2022
Q1 		$437K Buy
+2,074
New +$451K 0.07% 254
2021
Q3 		$518K Buy
1,829
+430
+31% +$141K 0.09% 230
2021
Q2 		$484K Buy
1,399
+5
+0.4% +$1.51K 0.09% 232
2021
Q1 		$390K Hold
1,394
– – 0.08% 234
2020
Q4 		$341K Buy
1,394
+13
+0.9% +$3.35K 0.08% 238
2020
Q3 		$392K Buy
1,381
+94
+7% +$26.2K 0.1% 200
2020
Q2 		$344K Hold
1,287
– – 0.13% 173
2020
Q1 		$407K Buy
1,287
+36
+3% +$10.9K 0.18% 136
2019
Q4 		$371K Buy
+1,251
New +$347K 0.15% 155

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eudaimonia Partners's BIIB Position: Q1 2024 in Review

Eudaimonia Partners held its Biogen (BIIB) position steady in Q1 2024 at 1,722 shares worth $371K. The position accounts for 0.09% of the portfolio, ranked #176.

Eudaimonia Partners first reported a position in BIIB in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.46M in Q2 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Eudaimonia Partners held 1,722 shares of Biogen worth $371K as of Q1 2024.
  • Eudaimonia Partners left its Biogen share count unchanged in Q1 2024.
  • Biogen made up 0.09% of Eudaimonia Partners's portfolio in Q1 2024, its #176 holding.
  • Eudaimonia Partners first reported a position in Biogen in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Biogen position peaked at $1.46M in Q2 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.